IBM Micromedex Drug Ref latest version
IBM Micromedex Drug Ref for Internet Subscribers is included free of charge to those who have an online subscription to IBM Micromedex products.
Access to IBM Micromedex Drug Ref for Internet Subscribers requires a password. Once you’ve downloaded the app, follow these instructions to obtain the password (which only needs to be entered once per year):
1. Login to IBM Micromedex® through your online subscription.
2. Click “Download Center” near the top of the application.
3. Refer to the detailed downloading instructions, which include your password for activating the mobile app at no charge.
If you cannot locate the “Download Center” link, or have other questions related to this app, please contact support via https://www.ibm.com/support/home/pages/support-guide/?product=4592222.
Access the evidence-based content you rely on in your IBM Micromedex, anytime, anywhere, via your iPhone and iPad.
IBM Micromedex Drug Ref for Internet Subscribers provides clinical care professionals with on-the-go access to the industry’s most trusted drug information, when and where it’s needed most. Users will find peace of mind knowing the content is backed by the same thorough, unbiased editorial process as all IBM Micromedex.
Once content has been downloaded or updated an internet connection is not required, allowing for access at anytime from anywhere.
The app is part of the IBM Micromedex Medication Management apps bundle, which includes Micromedex Drug Interactions and Micromedex IV Compatibility. The trio is an inexpensive solution to your on-the-go medication management needs.
IBM Micromedex Drug Ref for Internet Subscribers contains concise information on 4500+ search terms, covering common needs such as:
• Adult and pediatric dosage
• Adverse effects (separated into “common” and “serious”)
• Drug interactions
As well as:
• Black box warnings
• Breast feeding
• Common trade names
• Dose adjustments
• Generic names, including selected combination products
• How supplied
• Indications (differentiated as “FDA labeled” and “non-FDA labeled”)
• Mechanism of action
• Pregnancy category
• Therapeutic class